IBSA USA Renews Partnership With Professional Golfer Aza Muñoz to Promote Tirosint®-SOL
IBSA USA has renewed its partnership with professional golfer Azahara (Aza) Muñoz to promote Tirosint®-SOL (levothyroxine sodium) oral solution, a unique liquid hypothyroidism treatment, through the 2025 golf season.
- IBSA USA has renewed its partnership with professional golfer Azahara (Aza) Muñoz to promote Tirosint®-SOL (levothyroxine sodium) oral solution, a unique liquid hypothyroidism treatment, through the 2025 golf season.
- Muñoz, who has Hashimoto’s thyroiditis that results in hypothyroidism, has found relief since she began taking Tirosint-SOL and regained control over her hypothyroid symptoms.
- She attributes her restored energy and improved symptom relief to this innovative treatment option.
- I’ve experienced significant improvements in my energy levels and overall well-being,” said Muñoz.